Has Richard Berry, MD received payments from drug or device companies?

Yes. Drug and device makers reported $592 in general payments to Richard Berry, MD across 22 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Richard Berry, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Richard Berry, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Richard Berry, MD

Dermatology · Brooklyn, NYNPI 1497756183

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Pfizer at 36.1% of the total. Reporting peaked in 2022 at $243 and has fallen 94.6% since, to $13 in 2024. That places this record below the midpoint for dermatology clinicians in NY, where the typical reported total is $2,360.

$592in general payments, 2019–2025

Across 22 payments — averaging $26.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$214
Regeneron Healthcare Solutions, Inc.$94
Merck$45
Incyte Corporation$38
Sun Pharmaceutical Industries Inc.$37
Arcutis Biotherapeutics, Inc.$27
plus $137 from 6 others

What the payments were for

Food & beverage$592100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	6	$214
Regeneron Healthcare Solutions, Inc.	1	$94
Merck	3	$45
Incyte Corporation	2	$38
Sun Pharmaceutical Industries Inc.	2	$37
Arcutis Biotherapeutics, Inc.	2	$27
Helsinn Therapeutics (U.S.), Inc.	1	$25
Dermavant Sciences, Inc.	1	$24
LEO Pharma Inc.	1	$24
Almirall LLC	1	$22
Nabriva Therapeutics, PLC	1	$21
Amgen	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EUCRISA$107

How this compares

$592 in reported general payments places this provider in the 30th percentile of 1,151 dermatology providers in New York.

See all dermatology providers in New York →

Medicare billing

Part B allowed, 2024

$271,846

Medicare patients

541

Services billed

3,377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Betamethasone Dipropionate	431	$14,761
Halobetasol Propionate	166	$10,099
Clobetasol Propionate	95	$4,640
CiclopiroxCiclopirox Olamine	130	$3,770
Clindamycin Phosphate	65	$2,618
Mupirocin	417	$2,605
Mometasone Furoate	147	$2,454
Calcipotriene	15	$1,925
Triamcinolone Acetonide	351	$1,880
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc	38	$1,839
Ketoconazole	107	$1,184
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip	61	$1,088
Metronidazole	31	$977
Cephalexin	15	$713
Econazole Nitrate	13	$591

Paid to pharmacies, not to this prescriber.

Other dermatology in Brooklyn

Hilary BaldwinBrooklyn$1.5M
Steven BaranowitzBrooklyn$625K
Susan BardBrooklyn$425K
Nanette SilverbergBrooklyn$337K
Alexandra GolantNew York$3.6M
David CohenNew York$3M
Michael CameronNew York$2.6M
Saakshi KhattriNew York$2.4M
Amy WechslerNew York$2.4M
Jeffrey WeinbergKew Gardens$2.3M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →